Generate a tailored SOP for Dr. Adina Fischer. Improve your application with a focused, well-structured draft.
Dr. Fischer’s research focuses on characterizing risk and resilience factors in depression. She has been awarded the NIH Career Development Award (K23) and the Klingenstein Foundation Fellowship for her work on adolescent depression. Her program emphasizes clinical and translational research at Stanford, aiming to improve clinical care through the delivery and teaching of evidence-based interventions. Dr. Fischer's research also includes improving the understanding of protective biomarkers against depression, assessing the effects of cannabis on neurobiological function and depressive symptoms, and developing interventions for depressive disorders, especially in patients with co-occurring cannabis use. Dr. Fischer earned her BSc from the Massachusetts Institute of Technology in Brain and Cognitive Sciences and completed her MD/PhD at Dartmouth, where her doctoral research characterized the acute effects of cannabis in patients with schizophrenia. After completing her psychiatry residency at Stanford, she joined the research track with an NIH-funded postdoctoral fellowship in the Department of Psychiatry and Behavioral Sciences, focusing on the intersection of psychiatry, cannabis, and mental health.
Stanford University • Palo Alto, CA
Member of the University Medical Line in the Department of Psychiatry and Behavioral Sciences.
The Computer Science department emphasizes research potential. GRE General is currently optional but recommended for some tracks.